Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors
When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...
Two Chinook’s Edge students advanced to the national science fair after winning gold medals at the Central Alberta Rotary ...
The American League champions who took the Big Red Machine to seven games in the World Series will gather again for Friday's ...
Severely dry conditions during the winter of 2013-2014 blocked some species of salmon and steelhead trout from accessing ...
Press release The Friends of the Pool and Park Foundation would like to recognize Mike and Jocelyn Reid for their generous $1500 donation to the Chinook Pool and Park Rehabilitation Project. "This ...
18h
Zacks.com on MSNMore About ERJ’s C-390 AircraftEmbraer S.A. ERJ recently received a contract from Sweden for the supply of its four C-390 Millennium multi-mission aircraft.
FDA grants accelerated approval for Novartis's Vanrafia (atrasentan) for IgA nephropathy. The drug joins Tarpeyo and Filspari as well as Novartis' own Fabhalta in treating this rare kidney disease.
A new high school for Sylvan Lake, in partnership with Chinook’s Edge School Division and the Town of Sylvan Lake, tops Red ...
The executive director of the Central Alberta Collegiate Institute, and the Community Learning Campus for Chinook’s Edge and ...
17h
Zacks.com on MSNLockheed Martin Secures Contract to Support the F-35 Jet ProgramLockheed Martin Corporation LMT recently clinched a modification contract to support the F-35 jet program. The award has been ...
A massive wildfire that was burning out of control in the east of the Netherlands was caused by an Army drill, the Dutch ...
After decades of conflict, farmers and tribes say they’re working in concert to restore salmon habitat in the Klamath Basin. But two dams remain - one that blocks fish passage another that plays a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results